Paul M. Tulkens

21.4k citations
348 papers · 16.4k indexed · 3 hit papers · h-index 66
Topics
Antibiotics Pharmacokinetics and Efficacy (132 papers)Antibiotic Resistance in Bacteria (87 papers)Antimicrobial Resistance in Staphylococcus (75 papers)

In The Last Decade

Paul M. Tulkens

338 papers receiving 15.6k citations

Hit Papers

Lysosomotropic agents197420261991200819741999199950010001.5k

Peers

Paul M. Tulkens
Comparison fields: 5 of 173
  • Molecular Biology 6.0k
  • Pharmacology 4.7k
  • Molecular Medicine 3.5k
  • Infectious Diseases 3.0k
  • Epidemiology 2.6k
Replace David N. Gilbert with:
David N. Gilbert United States
Johan W. Mouton Netherlands
Roger L. Nation Australia
Harold C. Neu United States
Alan Forrest United States
Gerard D. Wright Canada
Hartmut Derendorf United States
Jerome J. Schentag United States
Thierry Calandra Switzerland
William A. Craig United States
Paul M. Tulkens relative to David N. Gilbert United States David N. Gilbert's profile →
Citations per field
00.5×1.5×2.2×
David N. Gilbert · 1×
Citations per year

Countries citing papers authored by Paul M. Tulkens

Since Specialization
Citations

This map shows the geographic impact of Paul M. Tulkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Tulkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Tulkens more than expected).

Fields of papers citing papers by Paul M. Tulkens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Tulkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Tulkens. The network helps show where Paul M. Tulkens may publish in the future.

Co-authorship network of co-authors of Paul M. Tulkens

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Tulkens. A scholar is included among the top collaborators of Paul M. Tulkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Tulkens. Paul M. Tulkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 46
2
Transmission d’information au pharmacien d’officine après hospitalisation du patient : élaboration d’une feuille de transfert, évaluation prospective de son effet et enquête sur les besoins d’information des pharmaciens
1
3 150
4 26
5
inpatients: qualitative study Appropriateness of use of medicines in elderly
3
6
L'efflux des antibiotiques: un mécanisme ubiquitaire conduisant à la résistance. État de la question et implications microbiologiques et cliniques
1
7
Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
88
8 63
9
Molecular description of the interactions of aminoglycoside antibiotics with negatively-charged phospholipids. Theoretical molecular modelling and experimental results.
2
10
A Novel Model of Acute Lysosomal Thesaurismosis of Proximal Tubular Cells Associated With Marked Proliferation of Peritubular Interstitial-cells Induced By Poly-d-glutamic Acid in Rat-kidney
2
11 36
12
Renal Cortical Phospholipidosis in Diabetic and Control Rats Evaluated At Similar Cortical Gentamicin Accumulation
3
13
Kidney Phospholipidosis (plsis) and Recovery After Acute Exposure To Gentamicin (g) With Low and High-doses in An Infused Rat Model
1
14
S-86451, a New Derivative of Gentamicin With Reduced Nephrotoxicity - Biochemical, Morphological and Functional-studies
11
15
Gentamicin Induces a Loss of Activity of Acid Phospholipases-a in Rat-kidney Cortex
3
16 2
17
Cellular uptake and subcellular distribution of two non-steroidal anti-inflammatory drugs: indomethacin and ketoprofen.
5
18
Accumulation and localization of neutral red in cultured fibroblasts [proceedings].
3
19
Intracellular fate of plasma membrane antigens during endocytosis.
2
20
Lysosome overloading and dysfunction induced by streptomycin in cultured fibroblasts.
1

About Paul M. Tulkens

Paul M. Tulkens is a scholar working on Molecular Medicine, Pharmacology and Clinical Biochemistry, having authored 348 papers that have together received 16.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (132 papers), Antibiotic Resistance in Bacteria (87 papers) and Antimicrobial Resistance in Staphylococcus (75 papers). The work is most often cited by research in Molecular Medicine (3.5k citations), Pharmacology (4.7k citations) and Applied Microbiology and Biotechnology (552 citations). Paul M. Tulkens has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Françoise Van Bambeke, Marie‐Paule Mingeot‐Leclercq, André Trouet, Y. Glupczynski, Sandrine Lemaire, Thierry de Barsy, Christian de Duve, Brian D. Poole, Cristina Seral and Guy Laurent. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026